Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Schendel

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Bone Marrow Transplantation|August 10, 2000
Allogeneic vaccination for renal cell carcinoma: development and monitoringH Pohla, B Frankenberger, B Stadlbauer, et al.
Transplantation|March 1, 1993
Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejectionC Brockmeyer, M Ulbrecht, D J Schendel, et al.
The Journal of Gene Medicine|May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trialT H Brill, H R Kübler, H von Randenborgh, et al.
The Journal of Clinical Investigation|May 15, 1997
Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patientsJ Endl, H Otto, G Jung, et al.
Gene Therapy|November 12, 2010
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I studyJ Westermann, A Flörcken, G Willimsky, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Bone Marrow Transplantation|August 10, 2000
Allogeneic vaccination for renal cell carcinoma: development and monitoringH Pohla, B Frankenberger, B Stadlbauer, et al.
Transplantation|March 1, 1993
Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejectionC Brockmeyer, M Ulbrecht, D J Schendel, et al.
The Journal of Gene Medicine|May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trialT H Brill, H R Kübler, H von Randenborgh, et al.
The Journal of Clinical Investigation|May 15, 1997
Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patientsJ Endl, H Otto, G Jung, et al.
Gene Therapy|November 12, 2010
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I studyJ Westermann, A Flörcken, G Willimsky, et al.
Pageof 9